Cargando…
Early prediction of phenotypic severity in Citrullinemia Type 1
OBJECTIVE: Citrullinemia type 1 (CTLN1) is an inherited metabolic disease affecting the brain which is detectable by newborn screening. The clinical spectrum is highly variable including individuals with lethal hyperammonemic encephalopathy in the newborn period and individuals with a mild‐to‐modera...
Autores principales: | Zielonka, Matthias, Kölker, Stefan, Gleich, Florian, Stützenberger, Nicolas, Nagamani, Sandesh C. S., Gropman, Andrea L., Hoffmann, Georg F., Garbade, Sven F., Posset, Roland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764635/ https://www.ncbi.nlm.nih.gov/pubmed/31469252 http://dx.doi.org/10.1002/acn3.50886 |
Ejemplares similares
-
Predicting the disease severity in male individuals with ornithine transcarbamylase deficiency
por: Scharre, Svenja, et al.
Publicado: (2022) -
Long-term effects of medical management on growth and weight in individuals with urea cycle disorders
por: Posset, Roland, et al.
Publicado: (2020) -
Incidence, disease onset and short-term outcome in urea cycle disorders –cross-border surveillance in Germany, Austria and Switzerland
por: Nettesheim, Susanne, et al.
Publicado: (2017) -
Unmet Needs of Parents of Children with Urea Cycle Disorders
por: Scharping, Mara, et al.
Publicado: (2022) -
FDA orphan drug designations for lysosomal storage disorders – a cross-sectional analysis
por: Garbade, Sven F., et al.
Publicado: (2020)